Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashed A Ghandour

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Urology|July 5, 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failureJames M McKiernan, Dara D Holder, Rashed A Ghandour, et al.
Urologic Oncology|September 17, 2019
Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinomaNirmish Singla, Roy Elias, Rashed A Ghandour, et al.
Urologic Oncology|July 31, 2021
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinomaRashed A Ghandour, Yuval Freifeld, Joseph Cheaib, et al.
Cancer|August 11, 2020
Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospitalNathan Chertack, Rashed A Ghandour, Nirmish Singla, et al.
Urologic Oncology|May 21, 2020
Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinomaNirmish Singla, Alana Christie, Yuval Freifeld, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Urology|July 5, 2014
Phase II trial of intravesical nanoparticle albumin bound paclitaxel for the treatment of nonmuscle invasive urothelial carcinoma of the bladder after bacillus Calmette-Guérin treatment failureJames M McKiernan, Dara D Holder, Rashed A Ghandour, et al.
Urologic Oncology|September 17, 2019
Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinomaNirmish Singla, Roy Elias, Rashed A Ghandour, et al.
Urologic Oncology|July 31, 2021
Predictive model for systemic recurrence following cisplatin-based neoadjuvant chemotherapy and radical nephroureterectomy for high risk upper tract urothelial carcinomaRashed A Ghandour, Yuval Freifeld, Joseph Cheaib, et al.
Cancer|August 11, 2020
Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospitalNathan Chertack, Rashed A Ghandour, Nirmish Singla, et al.
Urologic Oncology|May 21, 2020
Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinomaNirmish Singla, Alana Christie, Yuval Freifeld, et al.
Pageof 3